Skip to main content
Fig. 4 | Journal of Translational Medicine

Fig. 4

From: A novel immune checkpoints-based signature to predict prognosis and response to immunotherapy in lung adenocarcinoma

Fig. 4

The prognostic signature-related biological pathways. A The primary genes in the novel immune checkpoint-based signature in patients with LUAD (Pearson |R|> 0.45). B GO and KEGG analysis of the genes. C The association between risk score and inflammatory activities in patients with LUAD. D corrgram of the prognostic signature and inflammatory metagenes

Back to article page

Journal of Translational Medicine

ISSN: 1479-5876

Contact us